Audited Consolidated and Audited Standalone Financial Result for Financial Year ended 31st March 2026.
SHARDACROP · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Sharda Cropchem Limited reported strong full-year results for FY 2025-26. Consolidated revenue from operations grew 22% to ₹526,759 lakhs from ₹431,985 lakhs in the prior year. Net profit surged 124% to ₹68,099 lakhs compared to ₹30,442 lakhs in FY 2024-25. The agrochemicals segment contributed ₹471,686 lakhs in revenue while non-agrochemicals added ₹55,073 lakhs. EBITDA margin expanded significantly from approximately 15% to 22%. The Board recommended a final dividend of Rs. 9 per equity share (face value Rs. 10). Statutory auditors B S R & Co. LLP issued an unmodified opinion with no qualifications.
The company delivered exceptional profit growth of over 100% driven by strong revenue expansion and margin improvement. The clean audit report with no qualifications is positive for investor confidence. The 22% revenue growth and sharp PAT increase indicate operational efficiency gains, which could support the stock price.